Merck & Co., Inc.

Healthcare

NYSE:MRK · New York Stock Exchange

Market Cap $296.43B Beta 0.22 P/E (TTM) 33.2

$120.02 -0.61%

-$0.74 today

52W Low $76.66High $125.14

Vol 4.66M · Avg 9.70M

EPS (TTM)$3.61

Div Yield2.77%

Drug Manufacturers - General

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+51.98%

Period High

$123.18

Period Low

$76.14

Latest

$120.00

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Novartis AG

NYSE:NVS

$292.83B

AstraZeneca PLC

NYSE:AZN

$278.74B

Novo Nordisk A/S

NYSE:NVO

$196.44B

Amgen Inc.

NASDAQ:AMGN

$191.12B

Thermo Fisher Scientific Inc.

NYSE:TMO

$174.59B

Gilead Sciences, Inc.

NASDAQ:GILD

$155.61B

Abbott Laboratories

NYSE:ABT

$153.01B

Pfizer Inc.

NYSE:PFE

$149.30B

GSK plc

NYSE:GSK

$106.61B

Sanofi

NASDAQ:SNY

$106.50B

What is the latest MRK filing?

The latest filing shown is 4 dated Jun 2, 2026.

How many recent filings does MRK have?

Intrinsic Alpha currently shows 20 recent filings for MRK.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.